These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 21885975)

  • 1. Necrotizing autoimmune myopathy.
    Liang C; Needham M
    Curr Opin Rheumatol; 2011 Nov; 23(6):612-9. PubMed ID: 21885975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
    Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
    Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired necrotizing myopathies.
    Allenbach Y; Benveniste O
    Curr Opin Neurol; 2013 Oct; 26(5):554-60. PubMed ID: 23995277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and myositis: the role of anti-HMGCR antibodies.
    Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I
    Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies].
    Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment and outcomes in necrotising autoimmune myopathy: An Australian perspective.
    Ashton C; Junckerstorff R; Bundell C; Hollingsworth P; Needham M
    Neuromuscul Disord; 2016 Nov; 26(11):734-740. PubMed ID: 27665513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
    Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
    J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin induced necrotizing autoimmune myopathy.
    Babu S; Li Y
    J Neurol Sci; 2015 Apr; 351(1-2):13-17. PubMed ID: 25765229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy.
    Kassardjian CD; Lennon VA; Alfugham NB; Mahler M; Milone M
    JAMA Neurol; 2015 Sep; 72(9):996-1003. PubMed ID: 26192196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Necrotizing autoimmune myopathies].
    Petiot P; Choumert A; Hamelin L; Devic P; Streichenberger N
    Rev Neurol (Paris); 2013; 169(8-9):650-5. PubMed ID: 23999024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
    Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
    Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune necrotising myopathy and HMGCR antibodies.
    Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
    Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-induced necrotizing myositis - a discrete autoimmune entity within the "statin-induced myopathy spectrum".
    Hamann PD; Cooper RG; McHugh NJ; Chinoy H
    Autoimmun Rev; 2013 Oct; 12(12):1177-81. PubMed ID: 23851103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
    Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
    Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of immune-mediated necrotizing myopathies and their treatments.
    Pinal-Fernandez I; Mammen AL
    Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrotizing myopathies: beyond statins.
    Mammen AL
    Curr Opin Rheumatol; 2014 Nov; 26(6):679-83. PubMed ID: 25203117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying statin-associated autoimmune necrotizing myopathy.
    Albayda J; Christopher-Stine L
    Cleve Clin J Med; 2014 Dec; 81(12):736-41. PubMed ID: 25452351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
    Mohassel P; Mammen AL
    Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.